Green Thumb Industries (OTCMKTS:GTBIF) Releases Earnings Results, Misses Estimates By $0.02 EPS

Posted by Caroline Horne on Feb 27th, 2025

Green Thumb Industries (OTCMKTS:GTBIF – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.02), Zacks reports. Green Thumb Industries had a return on equity of 3.39% and a net margin of 5.38%.

Green Thumb Industries Trading Up 3.6 %

OTCMKTS GTBIF opened at $6.98 on Thursday. The company has a market capitalization of $1.48 billion, a PE ratio of 29.08 and a beta of 1.32. Green Thumb Industries has a twelve month low of $6.60 and a twelve month high of $16.33. The business’s 50-day moving average price is $7.37 and its 200 day moving average price is $9.02.

Analyst Ratings Changes

Separately, Roth Capital raised Green Thumb Industries to a “strong-buy” rating in a report on Sunday, November 10th. Two research analysts have rated the stock with a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Strong Buy” and a consensus price target of $16.50.

Check Out Our Latest Stock Report on Green Thumb Industries

About Green Thumb Industries

(Get Free Report)

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.